Laminin Beta-1 Monoclonal Antibody

Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biol

Introducing the Laminin Beta-1 Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of biomedical research. This meticulously crafted antibody is meticulously engineered to target and bind specifically to the Laminin Beta-1 protein, a crucial component of the extracellular matrix.

With its exceptional specificity and high affinity, this monoclonal antibody offers unparalleled accuracy and reliability in detecting and quantifying Laminin Beta-1. Its advanced formulation ensures minimal cross-reactivity, guaranteeing precise and reproducible results in a wide range of experimental applications.

The Laminin Beta-1 Monoclonal Antibody boasts exceptional versatility, making it an indispensable tool for researchers in various disciplines. Whether investigating cellular adhesion, tissue development, or disease progression, this antibody provides invaluable insights into the intricate mechanisms underlying these processes.

Furthermore, this antibody's exceptional performance is complemented by its ease of use. Its user-friendly design allows for seamless integration into existing laboratory protocols, facilitating efficient and streamlined experimentation. Additionally, its long shelf life ensures consistent performance, eliminating the need for frequent reordering and minimizing experimental variability.

In summary, the Laminin Beta-1 Monoclonal Antibody represents a breakthrough in biomedical research, offering unrivaled specificity, reliability, and versatility. With its exceptional performance and user-friendly design, this antibody is poised to revolutionize the field, empowering researchers to unravel the complexities of cellular adhesion, tissue development, and disease progression with unprecedented precision.